Prevalence of the E318K MITF germline mutation in Italian melanoma patients: associations with histological subtypes and family cancer history
- PMID: 23167872
- DOI: 10.1111/pcmr.12047
Prevalence of the E318K MITF germline mutation in Italian melanoma patients: associations with histological subtypes and family cancer history
Abstract
A French and an Australian study have recently identified a rare germline functional variant in the microphthalmia-associated transcription factor (MITF) (E318K) that predisposes to familial and sporadic melanoma and to renal cell carcinoma (RCC), showing a new link between two tumour types with different risk factors and between deregulated sumoylation and cancer. The aim of this study was to test the prevalence of the MITF E318K mutation in 667 Italian melanoma patients. We observed significant associations between histological subtypes and family cancer history. Carriers exhibited a nearly threefold higher risk of developing melanoma compared with controls. Carriers were also more likely to have developed multiple primary melanomas (6.40-fold), compared with wt patients. Carriers with a personal and/or family history of pancreatic cancer and kidney cancer had a nearly 31- and eightfold higher risk of developing melanoma compared with wt patients. Our findings further support MITF as a medium-penetrance melanoma susceptibility gene, highlight a potential association with histological subtypes and suggest that MITF may predispose to pancreatic cancer.
© 2012 John Wiley & Sons A/S.
Similar articles
-
Cancer risks associated with the germline MITF(E318K) variant.Sci Rep. 2020 Oct 13;10(1):17051. doi: 10.1038/s41598-020-74237-z. Sci Rep. 2020. PMID: 33051548 Free PMC article.
-
Prevalence of MITF p.E318K in Patients With Melanoma Independent of the Presence of CDKN2A Causative Mutations.JAMA Dermatol. 2016 Apr;152(4):405-12. doi: 10.1001/jamadermatol.2015.4356. JAMA Dermatol. 2016. PMID: 26650189
-
Prevalence of the E318K and V320I MITF germline mutations in Polish cancer patients and multiorgan cancer risk-a population-based study.Cancer Genet. 2014 Apr;207(4):128-32. doi: 10.1016/j.cancergen.2014.03.003. Epub 2014 Mar 15. Cancer Genet. 2014. PMID: 24767713
-
A germline oncogenic MITF mutation and tumor susceptibility.Eur J Cell Biol. 2014 Jan-Feb;93(1-2):71-5. doi: 10.1016/j.ejcb.2013.10.002. Epub 2013 Oct 26. Eur J Cell Biol. 2014. PMID: 24290354 Review.
-
A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma.Nature. 2011 Oct 19;480(7375):94-8. doi: 10.1038/nature10539. Nature. 2011. PMID: 22012259
Cited by
-
Prevalence of CDKN2A, CDK4, POT1, BAP1, MITF, ATM, and TERT Pathogenic Variants in a Single-Center Retrospective Series of Patients With Melanoma and Personal or Family History Suggestive of Genetic Predisposition.Dermatol Pract Concept. 2024 Jul 1;14(3):e2024120. doi: 10.5826/dpc.1403a120. Dermatol Pract Concept. 2024. PMID: 39122510 Free PMC article.
-
Genetic profiling of a rare condition: co-occurrence of albinism and multiple primary melanoma in a Caucasian family.Oncotarget. 2017 May 2;8(18):29751-29759. doi: 10.18632/oncotarget.12777. Oncotarget. 2017. PMID: 27776349 Free PMC article.
-
The melanocyte lineage in development and disease.Development. 2015 Feb 15;142(4):620-32. doi: 10.1242/dev.106567. Development. 2015. PMID: 25670789 Free PMC article. Review.
-
A new glance at autophagolysosomal-dependent or -independent function of transcriptional factor EB in human cancer.Acta Pharmacol Sin. 2023 Aug;44(8):1536-1548. doi: 10.1038/s41401-023-01078-7. Epub 2023 Apr 3. Acta Pharmacol Sin. 2023. PMID: 37012494 Free PMC article. Review.
-
Cancer risks associated with the germline MITF(E318K) variant.Sci Rep. 2020 Oct 13;10(1):17051. doi: 10.1038/s41598-020-74237-z. Sci Rep. 2020. PMID: 33051548 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical